Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Stock Report

| More

Zydus announces second Phase 3 trial of Desidustat

Posted On: 2019-11-18 16:53:15

Zydus Cadila, an innovation-driven, global pharmaceutical company, announced the second Phase III DREAM-D trials of Desidustat, an Investigational New Drug (IND) targeted at treating anemia in dialysis dependent CKD patients.

Chronic kidney disease is a serious medical condition which is an unmet healthcare need involving gradual loss of functioning of kidneys eventually leading to kidney failure. More than 200 million people worldwide are estimated to be living with chronic kidney disease. In a chronic kidney disease condition, the kidneys fail to produce EPO and this leads to anemia.

Desidustat is a novel, oral, HIF-PH inhibitor being developed for treating anemia in CKD patients. This Phase III DREAM-D study will be a multicenter (50-60 sites in India), randomized, active controlled clinical trial to evaluate the efficacy and safety of Desidustat versus Epoetin for the treatment of anemia in patients with CKD who are on dialysis.

Speaking on the development, Mr. Pankaj R. Patel, Chairman, Zydus Group said, "Based on the positive proof-of-concept established in the Phase 2 clinical trials, we are committed to developing this novel drug, Desidustat that can benefit millions of CKD patients. We believe that Desidustat has the potential to provide an oral, safer alternative to the currently available therapy which is in an injectable form."

The primary end-point in Phase III DREAM-D study will be the efficacy of Desidustat tablet versus Epoetin alfa injection based on the change of hemoglobin (Hb) levels at 24 weeks. The secondary end-points will include number of hemoglobin (Hb) responders, time to achieve target range Hb level, percentage of time spent in target Hb range, serum hepcidin levels, serum potassium (K+) levels, vascular endothelial growth factor (VEGF) levels, lipid profile and lipoproteins.

Shares of CADILA HEALTHCARE LTD. was last trading in BSE at Rs.241.6 as compared to the previous close of Rs. 234.35. The total number of shares traded during the day was 112968 in over 2164 trades.

The stock hit an intraday high of Rs. 246.75 and intraday low of 236.65. The net turnover during the day was Rs. 27343676.

Source: Equity Bulls

Click here to send ur comments or to

Other Headlines:

Sadbhav Engineering Ltd reports Rs. 886.63 crore PAT in Q4 FY20

NLC India Ltd's project in Andaman commissioned

Swarnsarita Gems Ltd Q4 consolidated PAT at Rs. 0.26 crore

PNB Housing Finance Ltd reworks business plan for FY2020-21

Arihant Capital Markets Ltd posts Rs. 2.18 crore consolidated PAT in Q4 FY20

Inducto Steel Ltd Q4 FY20 net profit at Rs. 0.52 crore

Dai-Ichi Karkaria Limited enters into agreement for sale of land

Sun Pharma launches 'Thank you Doctor' campaign

Reliance and bp launch 'Jio-bp' partnership

Arihant Capital Markets Ltd Board approves Dividend for FY20

HPL Electric & Power Ltd Q4 FY20 consolidated PAT drops to Rs. 2.51 crore

HPL Electric & Power Limited board recommends final dividend of Rs. 0.15

TCS board declares interim dividend of Rs. 5 for FY2020-21

TCS Q1FY21 consolidated PAT lower at Rs. 7008 crore

Kabra Extrusiontechnik Ltd posts consolidated PAT of Rs. 0.74 crore in Q4

HCC FY20 Revenue at Rs. 3,676 Crore; EBITDA margin at 12.7%

Jaguar Land Rover Reports Q1 Fiscal 2020/21 Retail Sales

Muthoot Capital Services Limited completed transaction of Rs. 100.89 crores through securitization of portfolio

Vessel Seamec Gallant's contract extended for 1 year

W H Brady & Co. Ltd. Q4 FY20 consolidated loss at Rs. 0.24 crore

Arvind Fashions Ltd reports loss of Rs. 204.33 crore in Q4 FY2020

Vedanta readies for post-Covid economic recovery, strengthens its Advisory Board by appointing former Secretary, GoI and ex-SAIL Chief

Arvind Fashions Ltd signs agreement for sale of Flying Machine business

Ind-Ra affirms rating of Arvind SmartSpaces Limited

ALANKIT Ltd enters into Business Correspondent Agreement with IDBI Bank

Hexaware Launches COCO-Unified Teams Bot for Improved Employee Experiences & Seamless Return to Workplaces

Zensar featured in ISG's 2020 Digital Case Studies Book

Britannia Industries Ltd board to approve Q1 results on July 17, 2020

Flipkart Group and Arvind Fashions Strengthen Partnership

SBI Life Insurance Company Ltd board to consider Q1 results on July 21, 2020

BHEL successfully commissions World's first Solar PV Plant for Rail Traction application

Praj strides into the next frontier of Bioeconomy

Hitachi ABB Power Grids India wins INR 120 crore order for Indian Railways electrification

Karur Vysya Bank partners with Tata Motors to offer car loans at attractive terms

IIFL Finance Ltd allots 2000 NCDs

YES Bank files RHP for FPO

Linc Pen and Plastics Ltd update on FY21

Strides receives USFDA approval for Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules

ICICI Prudential Life Insurance Company Ltd board to approve 1st quarter FY21 results on July 21, 2020

Sharika Enterprises Ltd bags order from BHEL

Swelect Energy Systems Limited board recommends final dividend of Rs. 0.75

SpiceJet facilitates insurance of passengers for COVID-19 hospitalisation starting at Rs. 443/-

Shoppers Stop Limited opens new store at Phoenix Palassio - Lucknow

PI Industries Ltd closes QIP, fixes price as Rs. 1470

YES Bank has sold 2.66% stake in CG Power & Industrial Solutions Limited

NMDC's excellent performance at Bailadila Projects, Chhattisgarh, during lockdown

The Phoenix Mills Ltd. opens doors of its grand palatial shopping mall, Phoenix Palassio, in Lucknow

Swelect Energy Systems Ltd Q4 consolidated loss at Rs. 14.87 crore

Automotive Stampings and Assemblies Ltd reports loss in Q4 FY2020

SKY Industries Ltd posts loss of Rs. 0.63 crore in Q4 FY2020

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019